Cardiopulmonary effects of administration of a combination solution of xylazine, guaifenesin, and ketamine or inhaled isoflurane in mechanically ventilated calves

To compare the cardiopulmonary effects of administration of a solution of xylazine, guaifenesin, and ketamine (XGK) or inhaled isoflurane in mechanically ventilated calves undergoing surgery. 13 male calves 2 to 26 days of age. Procedures-In calves in the XGK group, anesthesia was induced (0.5 mL/kg...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of veterinary research 2007-12, Vol.68 (12), p.1287-1293
Hauptverfasser: Kerr, C.L, Windeyer, C, Boure, L.P, Mirakhur, K.K, McDonell, W
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1293
container_issue 12
container_start_page 1287
container_title American journal of veterinary research
container_volume 68
creator Kerr, C.L
Windeyer, C
Boure, L.P
Mirakhur, K.K
McDonell, W
description To compare the cardiopulmonary effects of administration of a solution of xylazine, guaifenesin, and ketamine (XGK) or inhaled isoflurane in mechanically ventilated calves undergoing surgery. 13 male calves 2 to 26 days of age. Procedures-In calves in the XGK group, anesthesia was induced (0.5 mL/kg) and maintained (2.5 mL/kg/h) with a combination solution of xylazine (0.1 mg/mL), guaifenesin (50 mg/mL), and ketamine (1.0 mg/mL). For calves in the isoflurane group, anesthesia was induced and maintained with isoflurane in oxygen. The rates of XGK infusion and isoflurane administration were adjusted to achieve suitable anesthetic depth. All calves received 100% oxygen and were mechanically ventilated to maintain end-tidal carbon dioxide concentrations from 35 to 40 mm Hg and underwent laparoscopic bladder surgery through an abdominal approach. Cardiopulmonary variables were measured before induction and at intervals up to 90 minutes after anesthetic induction. The quality of induction was excellent in all calves. The XGK requirements were 0.57 +/- 0.18 mL/kg and 2.70 +/- 0.40 mL/kg/h to induce and maintain anesthesia, respectively. Heart rate was significantly lower than baseline throughout the anesthetic period in the XGK group. Systolic arterial blood pressure was significantly higher in the XGK group, compared with the isoflurane group, from 5 to 90 minutes. Cardiac index was lower than baseline in both groups. Differences between groups in cardiac index and arterial blood gas values were not significant. Administration of XGK resulted in excellent anesthetic induction and maintenance with cardiopulmonary alterations similar to those associated with isoflurane in mechanically ventilated calves.
doi_str_mv 10.2460/ajvr.68.12.1287
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69017136</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>69017136</sourcerecordid><originalsourceid>FETCH-LOGICAL-c360t-6d1212007225db4a24ff5780f0d29b06de15522f28c2427b96202f22d4bcd2ec3</originalsourceid><addsrcrecordid>eNpFkU1v1DAQhi1ERZfCmRv4xKnZjieJkxzRqnxIlXqAni3HH62LYy92smL5Of2leNlFlSyN_M4zr0bzEvKOwRobDlfycZfWvF8zLK_vXpAVG5q6annPXpIVAGA18KY9J69zfgQoDGtfkXPWQ4tdjSvytJFJu7hd_BSDTHtqrDVqzjRaKvXkgstzkrOL4Z9CVZxGF45Cjn753_m99_KPC-aS3i_SWRNMduGSyqDpTzPLYmRoTNSFB-mNpi5H65cki-oCnYx6kMEp6f2e7kyYnZdzoYqwM_kNObPSZ_P2VC_I3efrH5uv1c3tl2-bTzeVqjnMFdcMGQJ0iK0eG4mNtW3XgwWNwwhcG9a2iBZ7hQ1248ARyg91MyqNRtUX5OPRd5vir8XkWUwuK-N92TIuWfABWMdqXsCrI6hSzDkZK7bJTeV4goE4xCIOsQjeC4biEEuZeH-yXsbJ6Gf-lEMBPhwBK6OQ98llcfcdgdUAfcO6ntd_AfCgloU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69017136</pqid></control><display><type>article</type><title>Cardiopulmonary effects of administration of a combination solution of xylazine, guaifenesin, and ketamine or inhaled isoflurane in mechanically ventilated calves</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Kerr, C.L ; Windeyer, C ; Boure, L.P ; Mirakhur, K.K ; McDonell, W</creator><creatorcontrib>Kerr, C.L ; Windeyer, C ; Boure, L.P ; Mirakhur, K.K ; McDonell, W</creatorcontrib><description>To compare the cardiopulmonary effects of administration of a solution of xylazine, guaifenesin, and ketamine (XGK) or inhaled isoflurane in mechanically ventilated calves undergoing surgery. 13 male calves 2 to 26 days of age. Procedures-In calves in the XGK group, anesthesia was induced (0.5 mL/kg) and maintained (2.5 mL/kg/h) with a combination solution of xylazine (0.1 mg/mL), guaifenesin (50 mg/mL), and ketamine (1.0 mg/mL). For calves in the isoflurane group, anesthesia was induced and maintained with isoflurane in oxygen. The rates of XGK infusion and isoflurane administration were adjusted to achieve suitable anesthetic depth. All calves received 100% oxygen and were mechanically ventilated to maintain end-tidal carbon dioxide concentrations from 35 to 40 mm Hg and underwent laparoscopic bladder surgery through an abdominal approach. Cardiopulmonary variables were measured before induction and at intervals up to 90 minutes after anesthetic induction. The quality of induction was excellent in all calves. The XGK requirements were 0.57 +/- 0.18 mL/kg and 2.70 +/- 0.40 mL/kg/h to induce and maintain anesthesia, respectively. Heart rate was significantly lower than baseline throughout the anesthetic period in the XGK group. Systolic arterial blood pressure was significantly higher in the XGK group, compared with the isoflurane group, from 5 to 90 minutes. Cardiac index was lower than baseline in both groups. Differences between groups in cardiac index and arterial blood gas values were not significant. Administration of XGK resulted in excellent anesthetic induction and maintenance with cardiopulmonary alterations similar to those associated with isoflurane in mechanically ventilated calves.</description><identifier>ISSN: 0002-9645</identifier><identifier>EISSN: 1943-5681</identifier><identifier>DOI: 10.2460/ajvr.68.12.1287</identifier><identifier>PMID: 18052732</identifier><language>eng</language><publisher>United States</publisher><subject>anesthesia ; Anesthesia, Inhalation - veterinary ; Anesthesia, Intravenous - veterinary ; Anesthetics - administration &amp; dosage ; Anesthetics - pharmacology ; Animals ; blood chemistry ; blood gases ; blood pressure ; Blood Pressure - drug effects ; breathing ; calves ; carbon dioxide ; cardiac index ; cardiac output ; cardiopulmonary effects ; cardiovascular system ; Cattle - physiology ; dosage ; Drug Therapy, Combination ; guaifenesin ; Guaifenesin - administration &amp; dosage ; Guaifenesin - pharmacology ; heart rate ; Heart Rate - drug effects ; intranasal administration ; intravenous injection ; isoflurane ; Isoflurane - administration &amp; dosage ; Isoflurane - pharmacology ; ketamine ; Ketamine - administration &amp; dosage ; Ketamine - pharmacology ; Male ; oxygen ; Respiration, Artificial - veterinary ; respiratory system ; Time Factors ; xylazine ; Xylazine - administration &amp; dosage ; Xylazine - pharmacology</subject><ispartof>American journal of veterinary research, 2007-12, Vol.68 (12), p.1287-1293</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c360t-6d1212007225db4a24ff5780f0d29b06de15522f28c2427b96202f22d4bcd2ec3</citedby><cites>FETCH-LOGICAL-c360t-6d1212007225db4a24ff5780f0d29b06de15522f28c2427b96202f22d4bcd2ec3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,778,782,27911,27912</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18052732$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kerr, C.L</creatorcontrib><creatorcontrib>Windeyer, C</creatorcontrib><creatorcontrib>Boure, L.P</creatorcontrib><creatorcontrib>Mirakhur, K.K</creatorcontrib><creatorcontrib>McDonell, W</creatorcontrib><title>Cardiopulmonary effects of administration of a combination solution of xylazine, guaifenesin, and ketamine or inhaled isoflurane in mechanically ventilated calves</title><title>American journal of veterinary research</title><addtitle>Am J Vet Res</addtitle><description>To compare the cardiopulmonary effects of administration of a solution of xylazine, guaifenesin, and ketamine (XGK) or inhaled isoflurane in mechanically ventilated calves undergoing surgery. 13 male calves 2 to 26 days of age. Procedures-In calves in the XGK group, anesthesia was induced (0.5 mL/kg) and maintained (2.5 mL/kg/h) with a combination solution of xylazine (0.1 mg/mL), guaifenesin (50 mg/mL), and ketamine (1.0 mg/mL). For calves in the isoflurane group, anesthesia was induced and maintained with isoflurane in oxygen. The rates of XGK infusion and isoflurane administration were adjusted to achieve suitable anesthetic depth. All calves received 100% oxygen and were mechanically ventilated to maintain end-tidal carbon dioxide concentrations from 35 to 40 mm Hg and underwent laparoscopic bladder surgery through an abdominal approach. Cardiopulmonary variables were measured before induction and at intervals up to 90 minutes after anesthetic induction. The quality of induction was excellent in all calves. The XGK requirements were 0.57 +/- 0.18 mL/kg and 2.70 +/- 0.40 mL/kg/h to induce and maintain anesthesia, respectively. Heart rate was significantly lower than baseline throughout the anesthetic period in the XGK group. Systolic arterial blood pressure was significantly higher in the XGK group, compared with the isoflurane group, from 5 to 90 minutes. Cardiac index was lower than baseline in both groups. Differences between groups in cardiac index and arterial blood gas values were not significant. Administration of XGK resulted in excellent anesthetic induction and maintenance with cardiopulmonary alterations similar to those associated with isoflurane in mechanically ventilated calves.</description><subject>anesthesia</subject><subject>Anesthesia, Inhalation - veterinary</subject><subject>Anesthesia, Intravenous - veterinary</subject><subject>Anesthetics - administration &amp; dosage</subject><subject>Anesthetics - pharmacology</subject><subject>Animals</subject><subject>blood chemistry</subject><subject>blood gases</subject><subject>blood pressure</subject><subject>Blood Pressure - drug effects</subject><subject>breathing</subject><subject>calves</subject><subject>carbon dioxide</subject><subject>cardiac index</subject><subject>cardiac output</subject><subject>cardiopulmonary effects</subject><subject>cardiovascular system</subject><subject>Cattle - physiology</subject><subject>dosage</subject><subject>Drug Therapy, Combination</subject><subject>guaifenesin</subject><subject>Guaifenesin - administration &amp; dosage</subject><subject>Guaifenesin - pharmacology</subject><subject>heart rate</subject><subject>Heart Rate - drug effects</subject><subject>intranasal administration</subject><subject>intravenous injection</subject><subject>isoflurane</subject><subject>Isoflurane - administration &amp; dosage</subject><subject>Isoflurane - pharmacology</subject><subject>ketamine</subject><subject>Ketamine - administration &amp; dosage</subject><subject>Ketamine - pharmacology</subject><subject>Male</subject><subject>oxygen</subject><subject>Respiration, Artificial - veterinary</subject><subject>respiratory system</subject><subject>Time Factors</subject><subject>xylazine</subject><subject>Xylazine - administration &amp; dosage</subject><subject>Xylazine - pharmacology</subject><issn>0002-9645</issn><issn>1943-5681</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkU1v1DAQhi1ERZfCmRv4xKnZjieJkxzRqnxIlXqAni3HH62LYy92smL5Of2leNlFlSyN_M4zr0bzEvKOwRobDlfycZfWvF8zLK_vXpAVG5q6annPXpIVAGA18KY9J69zfgQoDGtfkXPWQ4tdjSvytJFJu7hd_BSDTHtqrDVqzjRaKvXkgstzkrOL4Z9CVZxGF45Cjn753_m99_KPC-aS3i_SWRNMduGSyqDpTzPLYmRoTNSFB-mNpi5H65cki-oCnYx6kMEp6f2e7kyYnZdzoYqwM_kNObPSZ_P2VC_I3efrH5uv1c3tl2-bTzeVqjnMFdcMGQJ0iK0eG4mNtW3XgwWNwwhcG9a2iBZ7hQ1248ARyg91MyqNRtUX5OPRd5vir8XkWUwuK-N92TIuWfABWMdqXsCrI6hSzDkZK7bJTeV4goE4xCIOsQjeC4biEEuZeH-yXsbJ6Gf-lEMBPhwBK6OQ98llcfcdgdUAfcO6ntd_AfCgloU</recordid><startdate>20071201</startdate><enddate>20071201</enddate><creator>Kerr, C.L</creator><creator>Windeyer, C</creator><creator>Boure, L.P</creator><creator>Mirakhur, K.K</creator><creator>McDonell, W</creator><scope>FBQ</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20071201</creationdate><title>Cardiopulmonary effects of administration of a combination solution of xylazine, guaifenesin, and ketamine or inhaled isoflurane in mechanically ventilated calves</title><author>Kerr, C.L ; Windeyer, C ; Boure, L.P ; Mirakhur, K.K ; McDonell, W</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c360t-6d1212007225db4a24ff5780f0d29b06de15522f28c2427b96202f22d4bcd2ec3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>anesthesia</topic><topic>Anesthesia, Inhalation - veterinary</topic><topic>Anesthesia, Intravenous - veterinary</topic><topic>Anesthetics - administration &amp; dosage</topic><topic>Anesthetics - pharmacology</topic><topic>Animals</topic><topic>blood chemistry</topic><topic>blood gases</topic><topic>blood pressure</topic><topic>Blood Pressure - drug effects</topic><topic>breathing</topic><topic>calves</topic><topic>carbon dioxide</topic><topic>cardiac index</topic><topic>cardiac output</topic><topic>cardiopulmonary effects</topic><topic>cardiovascular system</topic><topic>Cattle - physiology</topic><topic>dosage</topic><topic>Drug Therapy, Combination</topic><topic>guaifenesin</topic><topic>Guaifenesin - administration &amp; dosage</topic><topic>Guaifenesin - pharmacology</topic><topic>heart rate</topic><topic>Heart Rate - drug effects</topic><topic>intranasal administration</topic><topic>intravenous injection</topic><topic>isoflurane</topic><topic>Isoflurane - administration &amp; dosage</topic><topic>Isoflurane - pharmacology</topic><topic>ketamine</topic><topic>Ketamine - administration &amp; dosage</topic><topic>Ketamine - pharmacology</topic><topic>Male</topic><topic>oxygen</topic><topic>Respiration, Artificial - veterinary</topic><topic>respiratory system</topic><topic>Time Factors</topic><topic>xylazine</topic><topic>Xylazine - administration &amp; dosage</topic><topic>Xylazine - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kerr, C.L</creatorcontrib><creatorcontrib>Windeyer, C</creatorcontrib><creatorcontrib>Boure, L.P</creatorcontrib><creatorcontrib>Mirakhur, K.K</creatorcontrib><creatorcontrib>McDonell, W</creatorcontrib><collection>AGRIS</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of veterinary research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kerr, C.L</au><au>Windeyer, C</au><au>Boure, L.P</au><au>Mirakhur, K.K</au><au>McDonell, W</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cardiopulmonary effects of administration of a combination solution of xylazine, guaifenesin, and ketamine or inhaled isoflurane in mechanically ventilated calves</atitle><jtitle>American journal of veterinary research</jtitle><addtitle>Am J Vet Res</addtitle><date>2007-12-01</date><risdate>2007</risdate><volume>68</volume><issue>12</issue><spage>1287</spage><epage>1293</epage><pages>1287-1293</pages><issn>0002-9645</issn><eissn>1943-5681</eissn><abstract>To compare the cardiopulmonary effects of administration of a solution of xylazine, guaifenesin, and ketamine (XGK) or inhaled isoflurane in mechanically ventilated calves undergoing surgery. 13 male calves 2 to 26 days of age. Procedures-In calves in the XGK group, anesthesia was induced (0.5 mL/kg) and maintained (2.5 mL/kg/h) with a combination solution of xylazine (0.1 mg/mL), guaifenesin (50 mg/mL), and ketamine (1.0 mg/mL). For calves in the isoflurane group, anesthesia was induced and maintained with isoflurane in oxygen. The rates of XGK infusion and isoflurane administration were adjusted to achieve suitable anesthetic depth. All calves received 100% oxygen and were mechanically ventilated to maintain end-tidal carbon dioxide concentrations from 35 to 40 mm Hg and underwent laparoscopic bladder surgery through an abdominal approach. Cardiopulmonary variables were measured before induction and at intervals up to 90 minutes after anesthetic induction. The quality of induction was excellent in all calves. The XGK requirements were 0.57 +/- 0.18 mL/kg and 2.70 +/- 0.40 mL/kg/h to induce and maintain anesthesia, respectively. Heart rate was significantly lower than baseline throughout the anesthetic period in the XGK group. Systolic arterial blood pressure was significantly higher in the XGK group, compared with the isoflurane group, from 5 to 90 minutes. Cardiac index was lower than baseline in both groups. Differences between groups in cardiac index and arterial blood gas values were not significant. Administration of XGK resulted in excellent anesthetic induction and maintenance with cardiopulmonary alterations similar to those associated with isoflurane in mechanically ventilated calves.</abstract><cop>United States</cop><pmid>18052732</pmid><doi>10.2460/ajvr.68.12.1287</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0002-9645
ispartof American journal of veterinary research, 2007-12, Vol.68 (12), p.1287-1293
issn 0002-9645
1943-5681
language eng
recordid cdi_proquest_miscellaneous_69017136
source MEDLINE; Alma/SFX Local Collection
subjects anesthesia
Anesthesia, Inhalation - veterinary
Anesthesia, Intravenous - veterinary
Anesthetics - administration & dosage
Anesthetics - pharmacology
Animals
blood chemistry
blood gases
blood pressure
Blood Pressure - drug effects
breathing
calves
carbon dioxide
cardiac index
cardiac output
cardiopulmonary effects
cardiovascular system
Cattle - physiology
dosage
Drug Therapy, Combination
guaifenesin
Guaifenesin - administration & dosage
Guaifenesin - pharmacology
heart rate
Heart Rate - drug effects
intranasal administration
intravenous injection
isoflurane
Isoflurane - administration & dosage
Isoflurane - pharmacology
ketamine
Ketamine - administration & dosage
Ketamine - pharmacology
Male
oxygen
Respiration, Artificial - veterinary
respiratory system
Time Factors
xylazine
Xylazine - administration & dosage
Xylazine - pharmacology
title Cardiopulmonary effects of administration of a combination solution of xylazine, guaifenesin, and ketamine or inhaled isoflurane in mechanically ventilated calves
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T11%3A10%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cardiopulmonary%20effects%20of%20administration%20of%20a%20combination%20solution%20of%20xylazine,%20guaifenesin,%20and%20ketamine%20or%20inhaled%20isoflurane%20in%20mechanically%20ventilated%20calves&rft.jtitle=American%20journal%20of%20veterinary%20research&rft.au=Kerr,%20C.L&rft.date=2007-12-01&rft.volume=68&rft.issue=12&rft.spage=1287&rft.epage=1293&rft.pages=1287-1293&rft.issn=0002-9645&rft.eissn=1943-5681&rft_id=info:doi/10.2460/ajvr.68.12.1287&rft_dat=%3Cproquest_cross%3E69017136%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=69017136&rft_id=info:pmid/18052732&rfr_iscdi=true